News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Optimer Pharmaceuticals, Inc. Explores Collaborative Opportunities with C&O Pharmaceutical Technology


8/21/2007 11:01:08 AM

SAN DIEGO--(BUSINESS WIRE)--Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and C&O Pharmaceutical Technology (Holdings) Limited (Singapore Exchange Securities Trading: COPT) announced today that they have signed a non-binding Memorandum of Understanding (MOU) for the exploration of potential business collaborations in the U.S. and China. Under this MOU, the companies intend to jointly explore possible areas of cooperation, including sharing information on pre-clinical and clinical studies, screening and synthesizing new compounds, transferring technology, and licensing product candidates.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES